Case Studies

Background Alacrita`s client was nearing the completion of a pivotal Phase III with a novel antibody-based therapeutic. The product was designed to delay recurrence in cancer patients with minimum...

Challenge: After a seed investment, a startup biotech had built an IP portfolio in the field of glucosinolates, chemicals found in brassica vegetables, that are potent inducers of cytoprotective...

Alacrita is a leading provider of due diligence to the pharmaceutical industry. Its core team of partners, each of whom has industry experience, are supported by a team of expert, life science...